Market Access POV: ICER and Specialty Drug Coverage

Market Access POV: ICER and Specialty Drug Coverage
Valuate Health Consultancy has created a new Point of View (POV) to help market access teams better understand and leverage the work performed by ICER. Read the POV here.
If your organization needs help optimizing your commercialization and value strategy, contact our team today.
Archbow Consulting and Valuate Health Consultancy are sister companies under the Value and Access division of Omnicom Health Group. Learn more about our united organizations here.
For additional insights on this topic, you may also enjoy the following related posts:
For additional insights on this topic, you may also enjoy the following case studies:
Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.
Share in
Recent Posts
Navigating the Complex World of Pharmaceutical Returns Processing
Efficiently managing product returns is a critical lever for controlling costs, minimizing operational inefficiencies, and reducing end-to-end complexity.
What Happens in Vegas… Ends Up in Our Blog: Asembia 2025 Edition
Asembia 2025 clarified that the pharma landscape is rapidly evolving, with innovation and partnership as the driving forces.
Revolutionizing Patient Support: Creating a Seamless, Patient-Centered Experience
Building a coordinated access model is no longer just a difference – it’s a competitive necessity.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|